HKEX: 1345 - China Pioneer Pharma Holdings Ltd

Rentabilität für sechs Monate: -6.25%

Aktionsplan China Pioneer Pharma Holdings Ltd


Über das Unternehmen

Shanghai Pioneer Holding Ltd, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. The company offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas. It also sells medical devices, including ophthalmology, orthopedics, odontology, and wound care products.

Weitere Details
In addition, the company engages in sale of ancillary tools, dental devices, and imported in-licensed prescription products, as well as accessories leasing; research and development of denture and implants dentistry; Medical research and experimental development; and provision of metal finishing services. It sells its products to hospitals and medical institutions, and pharmacies. The company was formerly known as China Pioneer Pharma Holdings Limited. Shanghai Pioneer Holding Ltd was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pioneer Holding Ltd is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

EBITDA 0.1988
EV/EBITDA 3.13
ISIN KYG2162L1068
Industry Health Care Providers & Services
P/BV 0.6816
P/E 7.45
P/S 0.5925
Sector Health Care
Валюта hkd
Валюта отчета cny
Выручка 1.47
Див.доход ао 1.19
Дивиденд ао 0.0031
Сайт https://www.pioneer-pharma.com
Цена ао 2.07
Preisänderung pro Tag: -4.88% (2.05)
Preisänderung pro Woche: +1.56% (1.92)
Preisänderung pro Monat: -3.94% (2.03)
Preisänderung über 3 Monate: -5.34% (2.06)
Preisänderung über sechs Monate: -6.25% (2.08)
Preisänderung pro Jahr: +7.14% (1.82)
Preisänderung über 3 Jahre: +58.54% (1.23)
Preisänderung über 5 Jahre: +248.21% (0.56)
Preisänderung seit Jahresbeginn: +7.73% (1.81)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Gesamt: 2.5

Effizienz

Name Bedeutung Grad
ROA, % 0 0
ROE, % 0 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 3.6 9
DSI 0.8571 8.57
Gesamt: 6.8

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 10.94 2
Rentabilität Ebitda, % 83.61 9
Rentabilität EPS, % 25.17 4
Gesamt: 3.8
Weitere Details

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Zhang Xinzhou Li Executive Chairman 1963 (61 Jahr)
Mr. Yuewen Yang CEO & Executive Director 1988 (36 Jahre)
Mr. Quan Zhang General Manager of Dental Business Division & Executive Director 1964 (60 Jahre)
Mr. Yi Xue Chief Financial Officer 1975 (49 Jahre)
Yong Xiang Zheng General Manager of Investment Unit
Jie Wang Director of Personnel
Ms. Ka Man Ng A.C.I.S., A.C.S. Company Secretary 1978 (46 Jahre)

Adresse: China, Shanghai, No.15 Lane 88 Wuwei Road - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.pioneer-pharma.com